Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6128-6141
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6128
Table 4 Univariate and multivariate analysis of the clinicopathological factors for overall survival
CharacteristicsUnivariate analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
Age in yr
≤ 65Reference
> 651.665 (0.754-3.676)0.207
Gender
FemaleReference
Male1.099 (0.461-2.616)0.832
Comorbidities
AbsentReference
Present1.061 (0.491-2.291)0.881
Tumor location
GastricReferenceReference
Non-gastric4.428 (1.967-9.965)< 0.0013.812 (1.577-9.213)0.003
Tumor size in cm0.0210.556
Length ≤ 5ReferenceReference
5 < Length ≤ 102.279 (0.722-7.189)0.1601.381 (0.346-5.519)0.648
Length > 104.159 (1.498-11.549)0.0062.070 (0.539-7.959)0.290
Mitotic index, per 50 HPF< 0.0010.015
0-5ReferenceReference
6-103.120 (0.913-10.669)0.0704.129 (0.963-17.707)0.056
> 107.515 (3.045-18.548)< 0.0016.051 (1.762-20.778)0.004
Surgical approach0.684
OpenReference
Laparoscopic0.621 (0.213-1.815)0.384
Endoscopic0 (0-3.609E+275)0.968
Blood transfusion
NoReferenceReference
Yes2.832 (1.312-6.113)0.0081.298 (0.547-3.082)0.554
Intraoperative tumor rupture
NoReferenceReference
Yes5.094 (0.682-38.043)0.1133.264 (0.355-30.022)0.296
Imatinib treatment
YesReferenceReference
No2.952 (1.113-7.831)0.0307.841 (2.677-22.693)< 0.001
MGIST
AbsentReferenceReference
Present2.050 (0.889-4.726)0.0922.404 (0.830-6.966)0.106